Patient-derived protein corona-engineered bionanoarchitectures for personalized PDAC therapy
Pubblicato il 26-09-2026 - Azienda riservata in Italia
Organisation/Company Dipartimento di Medicina Molecolare- Sapienza università di Roma Research Field Medical sciences » Other Researcher Profile Recognised Researcher (R2) Leading Researcher (R4) First Stage Researcher (R1) Established Researcher (R3) Application Deadline 24 Sep 2026 - 23:59 (UTC) Country Italy Type of Contract To be defined Job Status Not Applicable Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No
Le informazioni riportate di seguito illustrano i requisiti del ruolo, l'esperienza richiesta ai candidati e le qualifiche associate.
Offer Description
The candidate will need to have solid experience in oncological nanomedicine and cell and molecular biology, with particular reference to the development and preclinical evaluation of nanostructured systems for drug and gene delivery.
Expertise is required in the preparation and physicochemical characterization of lipid nanoparticles and/or other nanocarriers, in the study of nano-bio interactions and protein corona, as well as in vitro evaluation by cell culture, viability/cytotoxicity assays, uptake and internalization, gene transfection and/or silencing, and expression analysis of molecular targets. xjncmbx Experience in in vivo preclinical studies, including evaluation of therapeutic efficacy, biodistribution and biological response in tumor animal models, is also required. Knowledge of animal testing procedures and possession of the relevant enabling training/certification shall be considered as highly preferential qualifications
professional science curriculum
qualifications
publicatoins
interview
- Italy
Eligibility of fellows: country/ies of residence:
- EUROPE
Eligibility of fellows: nationality/ies:
#J-18808-Ljbffr